메뉴 건너뛰기




Volumn 13, Issue 3, 2011, Pages

Biosimilars: A regulatory perspective from America

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; RECOMBINANT PROTEIN; RITUXIMAB; ANTIRHEUMATIC AGENT; GENERIC DRUG;

EID: 82155188444     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3310     Document Type: Note
Times cited : (43)

References (23)
  • 1
    • 82155177961 scopus 로고    scopus 로고
    • Public Health Service Act Sec. 262. Regulation of biological products
    • Public Health Service Act Sec. 262. Regulation of biological products. , http://www.fda.gov/RegulatoryInformation/Legislation/ucm149278.htm
  • 3
    • 82155174451 scopus 로고    scopus 로고
    • Yisaipu
    • Yisaipu. , http://www.cpgj-pharm.com/en/product_patient.asp?proid=22&action=intro
  • 5
    • 82155187689 scopus 로고    scopus 로고
    • Pipeline products
    • Pipeline products. , http://www.protalix.com/pipeline_products.html
  • 6
    • 82155174447 scopus 로고    scopus 로고
    • Biosimilar TuNEX® completes Phase I/II clinical trial in Taiwan, Phase I in Korea
    • Biosimilar TuNEX® completes Phase I/II clinical trial in Taiwan, Phase I in Korea. , http://www.mycenax.com.tw/webe/html/02news/news_show.aspx?page=1
  • 7
    • 82155187690 scopus 로고    scopus 로고
    • Avesthagen gets patent for Enbrel biosimilar
    • Singh K. Avesthagen gets patent for Enbrel biosimilar. Economic Times 2010,
    • (2010) Economic Times
    • Singh, K.1
  • 8
    • 82155169551 scopus 로고    scopus 로고
    • Korea's Celltrion and Aprogen in race to sell biosimilars in Japan
    • Korea's Celltrion and Aprogen in race to sell biosimilars in Japan. , http://sis.windhover.com/buy/abstract.php?id=28101102003
  • 9
    • 82155169550 scopus 로고    scopus 로고
    • LG Life Sciences' Pipeline Overview
    • LG Life Sciences' Pipeline Overview. , http://thinklgls.com/rnd/pipeline
  • 10
    • 82155174450 scopus 로고    scopus 로고
    • Dr. Reddy's Marketed Pharmaceutical Products
    • Dr. Reddy's Marketed Pharmaceutical Products. , http://www.drreddys.com/products/bio_mproducts.html#
  • 11
    • 82155187691 scopus 로고    scopus 로고
    • TL011 in severe, active rheumatoid arthritis patients
    • TL011 in severe, active rheumatoid arthritis patients. , http://clinicaltrials.gov/ct2/show/NCT01123070
  • 12
    • 82155169552 scopus 로고    scopus 로고
    • GP2013 in the treatment of RA patients refractory to or intolerant of standard therapy
    • GP2013 in the treatment of RA patients refractory to or intolerant of standard therapy. , http://www.clinicaltrials.gov/ct2/show/NCT01274182
  • 13
    • 82155177960 scopus 로고    scopus 로고
    • View Opportunities
    • View Opportunities. , http://www.sourcegenerics.com/viewAllListing.asp
  • 16
    • 33745096842 scopus 로고    scopus 로고
    • Eprex-associated pure red cell aplasia and leachates
    • 10.1038/nbt0606-613, 16763579
    • Schellekens H, Jiskoot W. Eprex-associated pure red cell aplasia and leachates. Nat Biotechnol 2006, 24:613-614. 10.1038/nbt0606-613, 16763579.
    • (2006) Nat Biotechnol , vol.24 , pp. 613-614
    • Schellekens, H.1    Jiskoot, W.2
  • 18
    • 82155174449 scopus 로고    scopus 로고
    • Federal Food, Drug, and Cosmetic Act (FD&C Act) SEC. 505. [21 USC §355] New Drugs
    • Federal Food, Drug, and Cosmetic Act (FD&C Act) SEC. 505. [21 USC §355] New Drugs. , http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/FDCActChapterVDrugsandDevices/ucm108125.htm
  • 19
    • 33644952525 scopus 로고    scopus 로고
    • Guideline on similar biological medicinal products
    • London: European Medicines Agency, Committee for Medicinal Products for Human Use
    • Committee for Medicinal Products for Human Use Guideline on similar biological medicinal products. 2005, London: European Medicines Agency, Committee for Medicinal Products for Human Use.
    • (2005)
  • 20
    • 42049123626 scopus 로고    scopus 로고
    • Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues
    • London: European Medicines Agency, Committee for Medicinal Products for Human Use
    • Committee for Medicinal Products for Human Use Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues. 2006, London: European Medicines Agency, Committee for Medicinal Products for Human Use.
    • (2006)
  • 21
    • 82155187686 scopus 로고    scopus 로고
    • Work plan for the biosimilar medicinal products working party (BMWP) 2011
    • London: European Medicines Agency, European Medicines Agency
    • European Medicines Agency Work plan for the biosimilar medicinal products working party (BMWP) 2011. 2010, London: European Medicines Agency, European Medicines Agency.
    • (2010)
  • 22
    • 82155187688 scopus 로고    scopus 로고
    • H. R. 3590--686. Patient Protection and Affordable Care Act. Title VII-- Improving Access to Innovative Medical Therapies. Subtitle A--Biologics Price Competition and Innovation. Sec. 7002. Approval Pathway for Biosimilar Biological Products
    • H. R. 3590--686. Patient Protection and Affordable Care Act. Title VII-- Improving Access to Innovative Medical Therapies. Subtitle A--Biologics Price Competition and Innovation. Sec. 7002. Approval Pathway for Biosimilar Biological Products. , http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/UCM216146.pdf
  • 23
    • 79959636415 scopus 로고    scopus 로고
    • Implementation of the Biologics Price Competition and Innovation Act of 2009
    • Implementation of the Biologics Price Competition and Innovation Act of 2009. , http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/ucm215089.htm


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.